Evidence map›Paper›PMID 39581203›Full record

ArticleLancet (London, England)2024

Halving premature death and improving quality of life at all ages: cross-country analyses of past trends and future directions.

Ole F Norheim, Angela Y Chang, Sarah Bolongaita, Mariana Barraza-Lloréns, Ayodamope Fawole, Lia Tadesse Gebremedhin, Eduardo González-Pier, Prabhat Jha, Emily K Johnson, Omar Karlsson and 11 more

Abstract read
In one paragraph

Article in Lancet (London, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ole F NorheimBergen Centre for Ethics and Priority Setting, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway. Electronic address: Ole.norheim@uib.no.
Angela Y ChangDanish Centre for Health Economics and Department of Public Health, Danish Institute for Advanced Study, University of Southern Denmark, Odense, Denmark.
Sarah BolongaitaBergen Centre for Ethics and Priority Setting, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Mariana Barraza-LlorénsBlutitude, Mexico City, Mexico.
Ayodamope FawoleDuke Global Health Institute, Duke University, Durham, NC, USA.
Lia Tadesse GebremedhinHarvard Ministerial Leadership Programme, Division of Policy Translation and Leadership Development, Harvard TH Chan School of Public Health, Harvard University, Boston, MA, USA.
Eduardo González-PierPalladium Group, Washington, DC, USA.
Prabhat JhaCenter for Global Health Research, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
Emily K JohnsonDanish Centre for Health Economics and Department of Public Health, Danish Institute for Advanced Study, University of Southern Denmark, Odense, Denmark.
Omar KarlssonDuke Global Health Institute, Duke University, Durham, NC, USA.
Mizan KirosBergen Centre for Ethics and Priority Setting, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Sarah LewingtonNuffield Department of Population Health, University of Oxford, Oxford, UK; Health Data Research, University of Oxford, Oxford, UK.
Wenhui MaoDuke Global Health Institute, Duke University, Durham, NC, USA.
Osondu OgbuojiDuke Global Health Institute, Duke University, Durham, NC, USA.
Muhammad PateMinister of Health and Social Welfare, Ministry of Health, Abuja, Nigeria.
Jennifer L SargentBergen Centre for Ethics and Priority Setting, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Xuyang TangCenter for Global Health Research, Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
David WatkinsDepartment of Global Health, University of Washington, Seattle, WA, USA.
Gavin YameyDuke Global Health Institute, Duke University, Durham, NC, USA.
Dean T JamisonDepartment of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
Richard PetoNuffield Department of Population Health, University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough death in old age is unavoidable, premature death-defined here as death before age 70 years-is not. To assess whether halving premature mortality by 2050 is feasible, we examined the large variation in premature death rates before age 70 years and trends over the past 50 years (1970-2019), covering ten world regions and the 30 most-populous nations. This analysis was undertaken in conjunction with the third report of The Lancet Commission on Investing in Health: Global Health 2050: the path to halving premature death by mid-century.

methodsIn this cross-country analysis of past mortality trends and future directions, all analyses on the probability of premature death (PPD) were conducted using life tables from the UN World Population Prospects 2024. For each sex, country, and year, probability of death was calculated from these life tables with 1-year age-specific mortality rates.

findingsGlobally, PPD decreased from 56% in 1970 to 31% in 2019, although some countries saw reversals because of conflict, social instability, or HIV and AIDS. Child mortality has decreased faster than adult mortality. Among all countries, 34 halved their PPD over three decades between 1970 and 2019. Among the 30 most-populous countries, seven countries, with varying levels of baseline PPD and income, halved their PPD in the past half century. Seven of the most-populous countries had average annual rates of improvement in the period 2010-19 that, if sustained, could lead to a halving of PPD by 2050, including Korea (3·9%), Bangladesh (2·8%), Russia (2·7%), Ethiopia (2·4%), Iran (2·4%), South Africa (2·4%), and Türkiye (2·3%).

interpretationHalving premature death by 2050 is feasible, although substantial investments in child and adult health are needed to sustain or accelerate the rate of improvement for high-performing and medium-performing countries. Particular attention must be paid to countries with very low or a worsening rate of improvement in PPD. By reducing premature mortality, more people will live longer and more healthy lives. However, as people live longer, the absolute number of years lived with chronic disease will increase and investments in services reducing chronic disease morbidity are needed.

fundingThe Norwegian Agency for Development Cooperation, the Bill & Melinda Gates Foundation, and a Norwegian Research Council Centre of Excellence grant.

Indexed as

Global HealthMortality, PrematureQuality of LifeAdolescentAdultAgedChildChild MortalityChild, PreschoolFemaleForecastingHumansInfantInfant, NewbornLife ExpectancyLife Tables

Identifiers

PMID39581203
PMCPMC11667436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.